Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q1 2026 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Vivos Therapeutics' First Quarter 2026 Conference Call.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 1,115,859 | $1,316,714 | 0.02% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.34 | 308,848 | $413,856.32 | 1,353,625 | 2026-03-31 | Filing | |
| $1.34 | 1,044,777 | $1,400,001.18 | 1,044,777 | 2026-03-31 | Filing | |
| $0.53 | 14,000 | $7,420.00 | 86,521 | 2023-06-20 | Filing | |
| $0.53 | 5,000 | $2,650.00 | 72,521 | 2023-06-16 | Filing | |
| $0.54 | 10,000 | $5,400.00 | 67,521 | 2023-06-16 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 273,329 | $322,528 | 0% | |
| 2. | 95,543 | $112,740 | 0% | |
| 3. | 42,500 | $50,150 | 0% | |
| 4. | 41,061 | $48,452 | 0% | |
| 5. | 35,684 | $42,108 | 0.01% |